VI
ALXN

Vestcor Inc’s Alexion Pharmaceuticals ALXN Stock Holding History

Vestcor Inc’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-82,719
Closed -$15.2M – 1377
2021
Q2 		$15.2M Sell
82,719
-389
-0.5% -$66.8K 0.51% 44
2021
Q1 		$12.7M Buy
83,108
+20,964
+34% +$3.24M 0.48% 44
2020
Q4 		$9.71M Buy
62,144
+49,390
+387% +$6.35M 0.4% 70
2020
Q3 		$1.46M Sell
12,754
-55
-0.4% -$5.93K 0.07% 302
2020
Q2 		$1.44M Buy
12,809
+8,071
+170% +$857K 0.07% 265
2020
Q1 		$425K Buy
4,738
+900
+23% +$88.3K 0.02% 438
2019
Q4 		$415K Buy
+3,838
New +$410K 0.02% 523

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return